Strategic Plan 2016-2020

The Crohn’s and Colitis Canada strategy sets out a clear view of where we need to be by 2020 as defined through the input of patients, donors, volunteers, staff and the research/medical community. The strategy is bold, aspirational, yet obtainable. 
We will build on our momentum and continue to be relentless in our promise to find the cures and improve the quality of life for those affected by these chronic diseases. Every single person with Crohn’s or colitis – young and old – inspires this strategy.

2020 Vision:

Crohn’s and Colitis Canada is a global force advancing transformational research and activating our community to improve the lives of people affected by Crohn’s and colitis in Canada.

Strategic priorities diagram

Our vision will become a reality by focusing our efforts on five overarching priorities. Crohn’s and Colitis Canada, with the support of our community, will:

  • Generate new science, knowledge and treatments for Crohn’s and colitis through a diverse research portfolio

  • Improve the quality of life and day to day experience of people living with or affected by Crohn’s and colitis

  • Diversify and grow our fundraising

  • Create an open conversation about Crohn’s and colitis and grow our profile as leaders

  • Support high performance and strategic action across the organization 

Thanks to you, we’ve made tremendous strides since our last plan – investing in world-class research, elevating awareness, advocating for change and engaging thousands through empowering patient programs. For us, it’s all about the quarter of a million Canadians living with Crohn’s or colitis and ensuring that every child and adult can live their life to the fullest.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest